Parkwood LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,202
Closed -$212K 184
2023
Q4
$212K Buy
+2,202
New +$212K 0.03% 115
2023
Q2
Sell
-3,560
Closed -$346K 144
2023
Q1
$346K Sell
3,560
-997
-22% -$96.9K 0.05% 123
2022
Q4
$472K Buy
4,557
+972
+27% +$101K 0.07% 106
2022
Q3
$304K Buy
3,585
+468
+15% +$39.7K 0.05% 123
2022
Q2
$258K Sell
3,117
-388
-11% -$32.1K 0.05% 125
2022
Q1
$270K Sell
3,505
-225
-6% -$17.3K 0.04% 117
2021
Q4
$330K Sell
3,730
-279
-7% -$24.7K 0.06% 103
2021
Q3
$310K Buy
4,009
+561
+16% +$43.4K 0.04% 106
2021
Q2
$288K Sell
3,448
-1,110
-24% -$92.7K 0.03% 111
2021
Q1
$344K Sell
4,558
-1,592
-26% -$120K 0.06% 102
2020
Q4
$539K Buy
+6,150
New +$539K 0.07% 97